Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related COV
Medtronic CEO: Covidien Merger Has Accelerated Growth Strategy
Morning Market Gainers
Medtronic Completes Covidien Acquisition for $50B - Analyst Blog (Zacks)
Related HFC
Must Watch Stocks for Today
Benzinga's M&A Chatter for Tuesday December 16, 2014
Just Happened: Analyst Day Catch-Up, U.S. Edition (Seeking Alpha)

Analysts at Raymond James downgraded Covidien plc (NYSE: COV) from “strong buy” to “outperform.” The target price for Covidien has been lowered from $88 to $81. Covidien's shares closed at $91.18 yesterday.

Analysts at Credit Suisse downgraded HollyFrontier (NYSE: HFC) from “outperform” to “neutral.” HollyFrontier's shares closed at $45.48 yesterday.

Barclays downgraded Air Products and Chemicals (NYSE: APD) from “overweight” to “equal-weight.” The price target for Air Products and Chemicals has been raised from $125 to $135. Air Products and Chemicals' shares closed at $128.06 yesterday.

Wells Fargo downgraded VeriSign (NASDAQ: VRSN) from “outperform” to “market perform.” VeriSign's shares closed at $50.73 yesterday.

Latest Ratings for COV

DateFirmActionFromTo
Nov 2014JefferiesMaintainsBuy
Oct 2014Morgan StanleyDowngradesOverweightEqualweight
Jul 2014CitigroupMaintainsBuy

View More Analyst Ratings for COV
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (APD + COV)

Around the Web, We're Loving...

Get Benzinga's Newsletters